Sale of 49 Percent Interest in Biomedical Sciences Development, Elementum

Issue of S$160,000,000 Green Notes due 2029

Announcement pursuant to Rule 706A of the Listing Manual

Record Date and Payment Date for Dividend

Establishment of Subsidiary in the UK

Change of Share Registrar

Profit Guidance for the Financial Year ending 31 December 2023

Change of Company Secretary - December 2023

Response to SGX's queries regarding trading activity on 19 June 2023

Appointment of Head of Finance

Resignation of Finance Director

Response to SGX's queries on Annual Report FY2022

Change of Company Secretary

Update on Term Loans Financing and Repayment of Bridging Loans

Clarification Announcement on News Article Published by Mingtiandi

Disposal of HB Centre 1 and HB Centre 2

Response to SGX’s queries on Results Announcement for FY2022

Announcement Pursuant to Rule 706A of the Listing Manual

Record Date and Payment Date for Dividend

Establishment of Board Sustainability Committee

Announcement pursuant to Rule 706A of the Listing Manual

Change of Company Secretary

Notice of Amended Tax Assessment to discharge tax pertaining to three investment properties

Divestment of Munich Office Asset, Elementum

Completion of site acquisition in Melbourne, Australia

Announcement pursuant to Rule 706A of the Listing Manual

Acquisition of 52 Lime Street “The Scalpel" in London

Notice of Amended Tax Assessment to discharge tax

Judgement obtained on appeal against Notice of Additional Tax Assessments raised by The Comptroller of Income Tax

Reconstitution of Board and Board Committees

Press release - Changes to Board appointments

Site acquisition in Melbourne, Australia

Site acquisitions in Australia

Reconstitution of Board and Board Committees

Yanlord and Ho Bee enter into agreement to extend co-operation to Tianjin, The PRC

Reconstitution of Board and Board Committees

Site acquisitions in Australia

Two new site acquisitions in Queensland, Australia

Award of Land Tender for Mixed Use Site at One-North for Biomedical Sciences and Office Use

Appointment of the CEO of HB Land Pty Ltd, a wholly-owned subsidiary of the Company in Australia

Establishment of subsidiaries and voluntary deregistration of associated companies in Australia

Acquisition of interest in an associated company - Nanjing Renbei Property Development Co., Ltd.

Announcement pursuant to Listing Rule 704(18)(a) of the Listing Manual

Announcement pursuant to Listing Rule 704(17)(a) of the Listing Manual

Acquisition of remaining 30% interest in HBS Investments Pte Ltd

Establishment of subsidiaries and joint venture companies

Acquisition of Ropemaker Place, a Grade A office building

Investment in European property fund and subscription of notes issued by Clouse S.A.

Establishment of new joint venture company and joint residential development in Wollert, Melbourne

Acquisition of interest in an associated company Zhuhai Yanlord Heyuan Land Co., Ltd.

Incorporation of Stream Field Investments Limited and acquisition of entire issued share capital of Emmatown Properties Ltd

Appointment of new directors and changes to the Board and Board committees

Ho Bee Land sells Rose Court in London for £94.5 million

Update of S$800,000,000 Multicurrency Medium Term Note Programme

Appointment of new director and changes to the Board and Board committees

Change in composition of the nominating committee

Establishment of wholly owned subsidiaries

Ho Bee Land acquires second West End London office within a week

Establishment of wholly owned subsidiary and acquisition of 39 Victoria Street, London

Notice of sale of investment property